Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.41 trillion and total revenue of $115.78 billion.
Market Cap
1.41T
Revenue
115.78B
Profits
-39.67B
PE Ratio
n/a
Profit Margin
-34.26%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 140.13B | 0.96% | 774,684 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 83.24B | 0.61% | 505,195 | 15.53B |
| 3 | ARGX | argenx SE | 64.17B | 0.83% | 142,227 | 5.32B |
| 4 | MRNA | Moderna, Inc. | 63.41B | 14.36% | 49,933,509 | 2.23B |
| 5 | RVMD | Revolution Medicines, Inc. | 45.31B | -0.09% | 1,377,214 | - |
| 6 | ONC | BeOne Medicines AG | 42.79B | 1.18% | 334,477 | 6.13B |
| 7 | RPRX | Royalty Pharma plc | 35.69B | 1.21% | 1,705,152 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.12B | 1.72% | 1,576,185 | 4.80B |
| 9 | BNTX | BioNTech SE | 28.65B | 1.09% | 1,358,780 | 3.03B |
| 10 | INSM | Insmed Incorporated | 27.06B | -0.07% | 2,372,873 | 1.14B |
| 11 | ROIV | Roivant Sciences Ltd. | 26.34B | 0.30% | 4,481,390 | 7.53M |
| 12 | INCY | Incyte Corporation | 26.29B | 1.36% | 1,162,029 | 5.82B |
| 13 | GMAB | Genmab A/S | 20.47B | 4.06% | 2,026,254 | 4.13B |
| 14 | JAZZ | Jazz Pharmaceuticals plc | 16.89B | 2.26% | 1,559,985 | 4.60B |
| 15 | ASND | Ascendis Pharma A/S | 16.61B | 0.41% | 333,516 | 1.20B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 15.72B | -0.83% | 1,469,291 | 713.07M |
| 17 | EXEL | Exelixis, Inc. | 14.05B | 3.98% | 2,024,326 | 2.44B |
| 18 | CORT | Corcept Therapeutics Incorporated | 13.36B | 0.27% | 576,766 | 830.81M |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.80B | 1.61% | 1,358,443 | 3.41B |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.55B | 2.48% | 981,994 | 669.50M |
| 21 | HALO | Halozyme Therapeutics, Inc. | 12.41B | 0.63% | 1,597,480 | 1.66B |
| 22 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.83B | 0.04% | 189,199 | 1.28B |
| 23 | TECH | Bio-Techne Corporation | 11.34B | -0.08% | 1,898,202 | 1.22B |
| 24 | ABVX | ABIVAX Société Anonyme | 11.17B | 1.53% | 853,335 | 5.67M |
| 25 | CYTK | Cytokinetics, Incorporated | 10.77B | 0.48% | 1,260,831 | 67.67M |
| 26 | AXSM | Axsome Therapeutics, Inc. | 10.76B | 0.04% | 731,296 | 776.57M |
| 27 | SMMT | Summit Therapeutics Inc. | 10.66B | 4.95% | 6,275,522 | - |
| 28 | IONS | Ionis Pharmaceuticals, Inc. | 10.56B | 2.47% | 2,431,573 | 874.09M |
| 29 | KRYS | Krystal Biotech, Inc. | 10.55B | 4.27% | 205,006 | 440.48M |
| 30 | KYMR | Kymera Therapeutics, Inc. | 10.53B | 4.62% | 930,561 | 105.00M |
| 31 | PRAX | Praxis Precision Medicines, Inc. | 10.28B | - | 294,290 | 7.46M |
| 32 | APGE | Apogee Therapeutics, Inc. | 10.17B | 0.04% | 585,593 | - |
| 33 | PTGX | Protagonist Therapeutics, Inc. | 9.74B | -2.67% | 664,522 | 281.99M |
| 34 | SYRE | Spyre Therapeutics, Inc. | 9.47B | 0.67% | 429,124 | - |
| 35 | PCVX | Vaxcyte, Inc. | 9.09B | -1.26% | 1,217,876 | - |
| 36 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.00B | 0.09% | 1,241,640 | 42.16M |
| 37 | IMVT | Immunovant, Inc. | 8.99B | 0.42% | 1,346,677 | - |
| 38 | IBRX | ImmunityBio, Inc. | 8.68B | 8.05% | 11,502,400 | 165.79M |
| 39 | CAI | Caris Life Sciences, Inc. | 7.92B | 7.19% | 6,821,253 | 989.61M |
| 40 | TGTX | TG Therapeutics, Inc. | 7.86B | -1.05% | 1,990,102 | 799.54M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.80B | 1.71% | 352,457 | 239.92M |
| 42 | SRRK | Scholar Rock Holding Corporation | 7.09B | 0.09% | 1,207,639 | - |
| 43 | CGON | CG Oncology, Inc. | 7.00B | 0.92% | 736,133 | 6.23M |
| 44 | ORKA | Oruka Therapeutics, Inc. | 6.74B | -0.59% | 1,308,015 | - |
| 45 | BLTE | Belite Bio, Inc | 6.51B | 1.77% | 61,849 | - |
| 46 | COGT | Cogent Biosciences, Inc. | 6.39B | 1.57% | 834,620 | - |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 6.37B | 1.41% | 472,293 | 618.07M |
| 48 | TVTX | Travere Therapeutics, Inc. | 6.32B | 2.74% | 1,507,031 | 591.33M |
| 49 | DNTH | Dianthus Therapeutics, Inc. | 6.27B | 1.85% | 552,011 | 1.90M |
| 50 | ERAS | Erasca, Inc. | 6.21B | 0.91% | 2,663,082 | - |
| 51 | PTCT | PTC Therapeutics, Inc. | 6.13B | 3.39% | 624,462 | 1.01B |
| 52 | DFTX | Definium Therapeutics, Inc. | 6.02B | 3.56% | 1,269,380 | - |
| 53 | CRSP | CRISPR Therapeutics AG | 5.89B | 6.70% | 2,080,342 | 13.39M |
| 54 | XENE | Xenon Pharmaceuticals Inc. | 5.85B | -0.23% | 418,012 | 7.50M |
| 55 | LGND | Ligand Pharmaceuticals Incorporated | 5.62B | 0.55% | 209,400 | 290.54M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 5.27B | 3.10% | 1,523,373 | 1.14B |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.92B | 1.35% | 1,459,196 | - |
| 58 | PBLS | Parabilis Medicines, Inc. | 4.85B | 2.08% | 286,021 | 148.00K |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.80B | -1.14% | 898,502 | - |
| 60 | CELC | Celcuity Inc. | 4.51B | 1.63% | 603,694 | - |
| 61 | RLAY | Relay Therapeutics, Inc. | 4.51B | 4.10% | 2,758,791 | 10.35M |
| 62 | ELVN | Enliven Therapeutics, Inc. | 4.47B | -0.23% | 804,350 | - |
| 63 | MANE | Veradermics, Incorporated | 4.28B | 3.95% | 786,962 | - |
| 64 | TNGX | Tango Therapeutics, Inc. | 4.18B | 1.06% | 2,283,192 | 53.81M |
| 65 | LEGN | Legend Biotech Corporation | 4.13B | 1.72% | 1,231,883 | 1.27B |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 4.10B | 6.09% | 1,022,092 | 234.13M |
| 67 | ABCL | AbCellera Biologics Inc. | 4.05B | 17.81% | 10,658,068 | 66.17M |
| 68 | RCUS | Arcus Biosciences, Inc. | 4.02B | 4.81% | 655,462 | 117.00M |
| 69 | VKTX | Viking Therapeutics, Inc. | 3.99B | 2.83% | 1,814,505 | - |
| 70 | DNLI | Denali Therapeutics Inc. | 3.98B | 3.02% | 1,120,452 | 3.60M |
| 71 | TLX | Telix Pharmaceuticals Limited | 3.93B | 0.09% | 95,740 | 890.79M |
| 72 | IOVA | Iovance Biotherapeutics, Inc. | 3.82B | 4.71% | 9,472,992 | 324.97M |
| 73 | GPCR | Structure Therapeutics Inc. | 3.56B | 1.86% | 463,838 | - |
| 74 | QURE | uniQure N.V. | 3.54B | 7.56% | 2,046,295 | 18.67M |
| 75 | IMNM | Immunome, Inc. | 3.34B | 4.91% | 1,928,004 | 4.02M |
| 76 | MBX | MBX Biosciences, Inc. | 3.30B | 3.36% | 273,986 | - |
| 77 | NAMS | NewAmsterdam Pharma Company N.V. | 3.27B | 1.82% | 1,986,351 | 7.12M |
| 78 | CLDX | Celldex Therapeutics, Inc. | 3.24B | 1.60% | 550,917 | 158.00K |
| 79 | IRON | Disc Medicine, Inc. | 3.16B | 1.82% | 320,943 | - |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 3.14B | -1.87% | 538,346 | 606.33M |
| 81 | ARQT | Arcutis Biotherapeutics, Inc. | 3.12B | 0.32% | 1,185,593 | 463.98M |
| 82 | ALMS | Alumis Inc. | 3.10B | 4.04% | 587,249 | 7.40M |
| 83 | BEAM | Beam Therapeutics Inc. | 3.10B | 9.53% | 2,185,812 | 156.04M |
| 84 | ZLAB | Zai Lab Limited | 2.94B | 2.07% | 705,450 | 449.61M |
| 85 | SLS | SELLAS Life Sciences Group, Inc. | 2.85B | -1.64% | 7,731,053 | - |
| 86 | NRIX | Nurix Therapeutics, Inc. | 2.80B | 2.59% | 580,222 | 36.77M |
| 87 | ATAI | AtaiBeckley Inc. | 2.76B | 0.81% | 9,685,459 | 4.47M |
| 88 | VRDN | Viridian Therapeutics, Inc. | 2.74B | 0.67% | 901,372 | 71.13M |
| 89 | GENB | Generate Biomedicines, Inc. | 2.62B | 15.01% | 4,685,125 | 26.48M |
| 90 | PHVS | Pharvaris N.V. | 2.61B | -0.21% | 827,438 | - |
| 91 | PGEN | Precigen, Inc. | 2.61B | 1.53% | 5,041,672 | 85.72M |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.60B | 2.88% | 3,807,367 | 717.00M |
| 93 | NKTR | Nektar Therapeutics | 2.56B | 1.72% | 349,018 | 54.59M |
| 94 | TRVI | Trevi Therapeutics, Inc. | 2.56B | -0.72% | 2,138,730 | - |
| 95 | VERA | Vera Therapeutics, Inc. | 2.54B | 4.63% | 2,487,962 | - |
| 96 | NUVB | Nuvation Bio Inc. | 2.49B | 5.03% | 3,735,927 | 169.90M |
| 97 | KOD | Kodiak Sciences Inc. | 2.48B | 6.02% | 571,078 | - |
| 98 | RAPP | Rapport Therapeutics, Inc. | 2.46B | 3.73% | 324,470 | 20.00M |
| 99 | OCUL | Ocular Therapeutix, Inc. | 2.39B | 0.93% | 1,841,741 | 52.06M |
| 100 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.34B | 6.76% | 5,695,607 | 208.78M |
| 101 | MLYS | Mineralys Therapeutics, Inc. | 2.33B | 4.23% | 701,259 | - |
| 102 | COAG | Hemab Therapeutics Holdings, Inc. | 2.32B | 6.39% | 527,131 | - |
| 103 | KLRA | Kailera Therapeutics, Inc. | 2.30B | 7.32% | 1,323,871 | - |
| 104 | HRMY | Harmony Biosciences Holdings, Inc. | 2.27B | 1.17% | 375,521 | 959.90M |
| 105 | URGN | UroGen Pharma Ltd. | 2.27B | 0.43% | 570,155 | 188.73M |
| 106 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | 1.09% | 780,569 | 311.51M |
| 107 | VCEL | Vericel Corporation | 2.21B | 2.17% | 465,741 | 306.30M |
| 108 | ZBIO | Zenas BioPharma, Inc. | 2.20B | 6.70% | 633,522 | 1.00M |
| 109 | MESO | Mesoblast Limited | 2.19B | 3.31% | 147,877 | 65.38M |
| 110 | XNCR | Xencor, Inc. | 2.18B | 1.05% | 1,563,054 | 104.97M |
| 111 | ADMA | ADMA Biologics, Inc. | 2.18B | 1.78% | 1,477,996 | 512.28M |
| 112 | BHVN | Biohaven Ltd. | 2.17B | 5.12% | 3,441,592 | - |
| 113 | STOK | Stoke Therapeutics, Inc. | 2.16B | 3.53% | 728,620 | 27.59M |
| 114 | PVLA | Palvella Therapeutics, Inc. | 2.14B | 1.71% | 191,987 | - |
| 115 | NBTX | Nanobiotix S.A. | 2.12B | 4.66% | 177,918 | 38.27M |
| 116 | AGIO | Agios Pharmaceuticals, Inc. | 2.02B | 3.86% | 742,173 | 98.34M |
| 117 | TSHA | Taysha Gene Therapies, Inc. | 2.02B | 3.85% | 1,690,382 | 5.49M |
| 118 | SRPT | Sarepta Therapeutics, Inc. | 2.00B | 4.36% | 1,696,066 | 1.97B |
| 119 | GHRS | GH Research PLC | 1.99B | 2.92% | 113,069 | - |
| 120 | KARD | Kardigan, Inc. | 1.96B | 1.36% | 229,953 | - |
| 121 | ZYME | Zymeworks Inc. | 1.95B | -4.52% | 2,076,337 | 37.13M |
| 122 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.03% | 1,235,741 | - |
| 123 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 2.27% | 333,258 | 1.13B |
| 124 | SEPN | Septerna, Inc. | 1.93B | 1.92% | 333,357 | 98.88M |
| 125 | IMCR | Immunocore Holdings plc | 1.93B | 2.16% | 257,337 | 430.78M |
| 126 | RXRX | Recursion Pharmaceuticals, Inc. | 1.91B | 9.54% | 22,430,525 | 54.86M |
| 127 | NTLA | Intellia Therapeutics, Inc. | 1.89B | 7.56% | 3,593,148 | 59.51M |
| 128 | DMRA | Damora Therapeutics, Inc. | 1.89B | 1.02% | 161,689 | - |
| 129 | VIR | Vir Biotechnology, Inc. | 1.81B | 8.07% | 2,961,219 | 303.23M |
| 130 | INBX | Inhibrx Biosciences, Inc. | 1.81B | 16.94% | 510,558 | 1.30M |
| 131 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 1.79% | 974,943 | 252.25M |
| 132 | BRVE | Braveheart Bio, Inc. | 1.77B | 0.51% | 155,334 | - |
| 133 | FTRE | Fortrea Holdings Inc. | 1.74B | -0.22% | 599,244 | 2.68B |
| 134 | ANAB | AnaptysBio, Inc. | 1.73B | -0.12% | 341,833 | 232.39M |
| 135 | AVLN | Avalyn Pharma Inc. | 1.69B | 1.35% | 108,362 | - |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.69B | 2.77% | 307,641 | 20.00M |
| 137 | ABSI | Absci Corporation | 1.65B | 8.94% | 2,333,724 | 1.56M |
| 138 | BCAX | Bicara Therapeutics Inc. | 1.63B | 4.24% | 410,308 | - |
| 139 | TRAX | First Tracks Biotherapeutics, Inc. | 1.61B | 4.23% | 441,583 | - |
| 140 | TYRA | Tyra Biosciences, Inc. | 1.59B | 2.30% | 317,813 | - |
| 141 | LBRX | LB Pharmaceuticals Inc | 1.57B | 1.22% | 217,010 | - |
| 142 | AAPG | Ascentage Pharma Group International | 1.56B | 0.48% | 3,296 | 94.61M |
| 143 | NVAX | Novavax, Inc. | 1.56B | 6.55% | 7,095,359 | 413.80M |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.55B | 10.93% | 961,652 | - |
| 145 | INVA | Innoviva, Inc. | 1.53B | 0.67% | 412,673 | 440.00M |
| 146 | APMD | Apnimed, Inc. | 1.52B | 6.79% | 480,424 | 120.15M |
| 147 | SLBT | SL Science Holding Limited | 1.51B | -2.58% | 58,859 | 3.27M |
| 148 | REPL | Replimune Group, Inc. | 1.49B | 7.41% | 2,891,083 | - |
| 149 | AKTS | Aktis Oncology, Inc. | 1.48B | 2.73% | 601,207 | 10.06M |
| 150 | CGEM | Cullinan Therapeutics, Inc. | 1.48B | 5.18% | 519,204 | - |
| 151 | ORIC | ORIC Pharmaceuticals, Inc. | 1.43B | 2.75% | 1,168,709 | - |
| 152 | MGTX | MeiraGTx Holdings plc | 1.43B | 0.61% | 689,525 | 397.50M |
| 153 | LTGO | Latigo Biotherapeutics, Inc. | 1.43B | 2.59% | 134,738 | - |
| 154 | ANRO | Alto Neuroscience, Inc. | 1.42B | 0.17% | 473,914 | - |
| 155 | SVRA | Savara Inc. | 1.42B | 0.72% | 1,608,464 | - |
| 156 | VOR | Vor Biopharma Inc. | 1.42B | 5.72% | 1,219,908 | - |
| 157 | OMER | Omeros Corporation | 1.40B | -0.21% | 1,127,849 | 38.42M |
| 158 | JBIO | Jade Biosciences, Inc. | 1.39B | 2.39% | 603,529 | - |
| 159 | DRTS | Alpha Tau Medical Ltd. | 1.36B | - | 472,691 | - |
| 160 | MNKD | MannKind Corporation | 1.34B | 2.21% | 3,193,654 | 393.63M |
| 161 | SPTX | Seaport Therapeutics, Inc. | 1.33B | 3.11% | 85,780 | - |
| 162 | MLTX | MoonLake Immunotherapeutics | 1.32B | 1.24% | 819,032 | - |
| 163 | IMTX | Immatics N.V. | 1.26B | 6.33% | 1,062,336 | 47.65M |
| 164 | ODTX | Odyssey Therapeutics, Inc. | 1.25B | 4.14% | 163,700 | 99.00K |
| 165 | GLUE | Monte Rosa Therapeutics, Inc. | 1.24B | 5.70% | 1,098,456 | 28.73M |
| 166 | SANA | Sana Biotechnology, Inc. | 1.23B | 8.47% | 2,999,173 | - |
| 167 | CRVS | Corvus Pharmaceuticals, Inc. | 1.22B | 3.34% | 642,145 | - |
| 168 | KURA | Kura Oncology, Inc. | 1.21B | 9.60% | 4,888,384 | 77.23M |
| 169 | JANX | Janux Therapeutics, Inc. | 1.14B | 0.43% | 1,074,338 | 24.00M |
| 170 | IVA | Inventiva S.A. | 1.13B | - | 381,242 | 7.94M |
| 171 | SLDB | Solid Biosciences Inc. | 1.06B | 7.97% | 1,260,146 | - |
| 172 | AVTX | Avalo Therapeutics, Inc. | 1.06B | 2.44% | 1,015,404 | 59.00K |
| 173 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.04B | 0.86% | 1,820,940 | 41.47M |
| 174 | CADL | Candel Therapeutics, Inc. | 1.04B | 5.75% | 1,342,512 | - |
| 175 | IMMX | Immix Biopharma, Inc. | 1.04B | 6.32% | 3,651,486 | - |
| 176 | WVE | Wave Life Sciences, Inc. | 1.03B | 2.54% | 2,409,494 | 65.37M |
| 177 | ABUS | Arbutus Biopharma Corporation | 1.03B | - | 8,907,504 | 181.72M |
| 178 | CLYM | Climb Bio, Inc. | 1.02B | 8.78% | 1,203,122 | - |
| 179 | HELP | Cybin Inc. | 1.02B | 7.41% | 2,998,550 | - |
| 180 | GERN | Geron Corporation | 995.83M | 1.97% | 9,843,735 | 204.56M |
| 181 | DSGN | Design Therapeutics, Inc. | 981.28M | 2.95% | 608,065 | - |
| 182 | ANNX | Annexon, Inc. | 976.33M | 1.78% | 2,941,736 | - |
| 183 | ACRS | Aclaris Therapeutics, Inc. | 961.94M | 3.57% | 3,353,214 | 8.22M |
| 184 | OLMA | Olema Pharmaceuticals, Inc. | 954.60M | 4.60% | 799,923 | - |
| 185 | ARDX | Ardelyx, Inc. | 941.93M | 1.07% | 3,418,065 | 450.89M |
| 186 | FTH | Faeth Therapeutics, Inc. | 892.01M | -0.55% | 365,140 | - |
| 187 | SGP | SpyGlass Pharma, Inc. | 889.72M | 1.29% | 60,332 | - |
| 188 | ANL | Adlai Nortye Ltd. | 884.83M | -2.97% | 100,195 | 18.06M |
| 189 | TBPH | Theravance Biopharma, Inc. | 884.18M | 0.12% | 332,379 | 104.31M |
| 190 | DBVT | DBV Technologies S.A. | 873.69M | 5.87% | 154,928 | 5.04M |
| 191 | RIGL | Rigel Pharmaceuticals, Inc. | 873.28M | 3.64% | 373,311 | 276.79M |
| 192 | FDMT | 4D Molecular Therapeutics, Inc. | 868.44M | 2.14% | 919,087 | 92.01M |
| 193 | NVCT | Nuvectis Pharma, Inc. | 843.54M | 8.46% | 276,414 | - |
| 194 | ACHV | Achieve Life Sciences, Inc. | 840.71M | 2.90% | 1,322,395 | - |
| 195 | ATTO | Attovia Therapeutics, Inc. | 830.89M | -6.35% | 189,232 | 1.35M |
| 196 | PHAR | Pharming Group N.V. | 830.52M | 2.71% | 21,438 | 366.48M |
| 197 | OBX | Obsidian Therapeutics, Inc. | 823.20M | 1.60% | 155,705 | - |
| 198 | SLN | Silence Therapeutics plc | 823.06M | 2.86% | 645,030 | 615.00K |
| 199 | NGNE | Neurogene Inc. | 817.26M | 3.03% | 504,318 | 925.00K |
| 200 | AURA | Aura Biosciences, Inc. | 810.97M | -1.01% | 1,131,920 | - |
| 201 | STTK | Shattuck Labs, Inc. | 808.93M | 2.03% | 869,571 | 1.00M |
| 202 | OCS | Oculis Holding AG | 800.05M | -1.67% | 192,366 | 1.45M |
| 203 | DRUG | Bright Minds Biosciences Inc. | 782.27M | 3.20% | 159,563 | - |
| 204 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 751.23M | 2.52% | 197,621 | - |
| 205 | ALLO | Allogene Therapeutics, Inc. | 749.72M | 6.90% | 6,156,597 | 4.64M |
| 206 | MNPR | Monopar Therapeutics Inc. | 743.84M | -0.48% | 133,183 | - |
| 207 | TECX | Tectonic Therapeutic, Inc. | 737.21M | 3.40% | 144,457 | - |
| 208 | CTMX | CytomX Therapeutics, Inc. | 734.32M | 2.43% | 4,027,234 | 18.30M |
| 209 | CBIO | Crescent Biopharma, Inc. | 727.62M | 0.18% | 129,672 | 11.88M |
| 210 | ASMB | Assembly Biosciences, Inc. | 719.34M | 0.14% | 553,712 | 74.85M |
| 211 | ZVRA | Zevra Therapeutics, Inc. | 714.98M | 3.35% | 820,198 | 136.07M |
| 212 | GYRE | Gyre Therapeutics, Inc. | 708.31M | 3.73% | 44,531 | 109.82M |
| 213 | PHAT | Phathom Pharmaceuticals, Inc. | 698.98M | 1.62% | 748,466 | 239.66M |
| 214 | MPLT | MapLight Therapeutics, Inc. | 696.92M | 10.39% | 703,442 | - |
| 215 | AGMB | AgomAb Therapeutics NV | 690.46M | 9.36% | 219,272 | - |
| 216 | EIKN | Eikon Therapeutics, Inc. | 679.77M | 12.46% | 567,202 | - |
| 217 | PRLD | Prelude Therapeutics Incorporated | 678.74M | 1.85% | 415,360 | 22.42M |
| 218 | OABI | OmniAb, Inc. | 677.52M | -1.06% | 1,466,684 | 38.46M |
| 219 | CRMD | CorMedix Inc. | 667.20M | 3.38% | 1,235,338 | 462.25M |
| 220 | PRME | Prime Medicine, Inc. | 660.02M | 14.15% | 2,982,299 | 4.07M |
| 221 | AUTL | Autolus Therapeutics plc | 649.44M | 4.27% | 1,518,694 | 117.39M |
| 222 | CTNM | Contineum Therapeutics, Inc. | 641.44M | 2.53% | 724,748 | - |
| 223 | VSTM | Verastem, Inc. | 641.19M | 3.21% | 1,189,160 | 87.53M |
| 224 | VALN | Valneva SE | 640.49M | 0.44% | 30,970 | 163.30M |
| 225 | SGMT | Sagimet Biosciences Inc. | 639.61M | 0.78% | 968,555 | - |
| 226 | MDXG | MiMedx Group, Inc. | 632.60M | 1.64% | 699,293 | 355.17M |
| 227 | ARVN | Arvinas, Inc. | 627.71M | 2.78% | 530,259 | 316.70M |
| 228 | ALT | Altimmune, Inc. | 622.46M | 2.89% | 3,812,852 | 31.00K |
| 229 | ZURA | Zura Bio Limited | 605.64M | 0.32% | 2,816,983 | - |
| 230 | ENTX | Entera Bio Ltd. | 600.80M | 1.46% | 429,944 | 42.00K |
| 231 | SCTX | Scribe Therapeutics Inc. | 588.66M | -16.23% | 315,999 | 36.28M |
| 232 | RGNX | REGENXBIO Inc. | 588.18M | 10.61% | 1,749,045 | 174.48M |
| 233 | ARTV | Artiva Biotherapeutics, Inc. | 575.44M | 2.17% | 266,349 | 251.00K |
| 234 | SPRY | ARS Pharmaceuticals, Inc. | 568.84M | 6.92% | 1,715,833 | 116.93M |
| 235 | OVID | Ovid Therapeutics Inc. | 568.32M | 3.19% | 1,449,265 | 1.58M |
| 236 | BLSM | BlossomHill Therapeutics, Inc. | 564.46M | 14.91% | 193,519 | - |
| 237 | KYTX | Kyverna Therapeutics, Inc. | 546.70M | 7.28% | 777,957 | - |
| 238 | CABA | Cabaletta Bio, Inc. | 545.94M | 3.87% | 3,964,928 | - |
| 239 | RZLT | Rezolute, Inc. | 523.38M | - | 1,798,768 | - |
| 240 | PROK | ProKidney Corp. | 523.02M | 7.45% | 698,528 | 818.00K |
| 241 | CCCC | C4 Therapeutics, Inc. | 516.71M | 2.44% | 4,285,679 | 35.04M |
| 242 | DNA | Ginkgo Bioworks Holdings, Inc. | 507.75M | 11.21% | 1,496,602 | 132.42M |
| 243 | EDIT | Editas Medicine, Inc. | 503.74M | 9.33% | 4,209,961 | 47.01M |
| 244 | EVMN | Evommune, Inc. | 500.47M | 0.88% | 340,343 | 10.00M |
| 245 | RLMD | Relmada Therapeutics, Inc. | 489.61M | 0.22% | 1,025,381 | - |
| 246 | QTTB | Q32 Bio Inc. | 485.84M | -0.24% | 598,207 | 53.74M |
| 247 | PRTA | Prothena Corporation plc | 483.59M | 0.32% | 363,694 | 54.53M |
| 248 | CAPR | Capricor Therapeutics, Inc. | 481.97M | 21.91% | 17,596,153 | 11.13M |
| 249 | PBYI | Puma Biotechnology, Inc. | 481.10M | 2.19% | 302,366 | 231.24M |
| 250 | EPRX | Eupraxia Pharmaceuticals Inc. | 478.87M | 1.92% | 561,973 | - |
| 251 | OCGN | Ocugen, Inc. | 474.75M | 2.94% | 4,592,023 | 4.58M |
| 252 | CMPX | Compass Therapeutics, Inc. | 455.62M | 5.42% | 2,284,019 | 850.00K |
| 253 | IKT | Inhibikase Therapeutics, Inc. | 455.19M | - | 453,410 | 1.00 |
| 254 | BNTC | Benitec Biopharma Inc. | 447.29M | 2.44% | 254,950 | - |
| 255 | ARCT | Arcturus Therapeutics Holdings Inc. | 438.85M | 7.67% | 2,099,735 | 29.37M |
| 256 | VOGX | Vogenx, Inc. | 438.82M | 2.60% | 136,005 | - |
| 257 | AVIR | Atea Pharmaceuticals, Inc. | 435.51M | -1.45% | 198,032 | - |
| 258 | LRMR | Larimar Therapeutics, Inc. | 434.23M | 2.72% | 1,081,637 | - |
| 259 | EYPT | EyePoint, Inc. | 431.49M | 2.77% | 3,738,871 | 2.79M |
| 260 | VTVT | vTv Therapeutics Inc. | 421.32M | 0.06% | 59,295 | 36.84M |
| 261 | LXEO | Lexeo Therapeutics, Inc. | 420.88M | 4.27% | 808,873 | - |
| 262 | RCKT | Rocket Pharmaceuticals, Inc. | 414.95M | 7.08% | 2,201,525 | - |
| 263 | XFOR | X4 Pharmaceuticals, Inc. | 412.45M | 2.72% | 390,704 | 15.85M |
| 264 | FENC | Fennec Pharmaceuticals Inc. | 410.64M | 2.72% | 196,877 | 59.22M |
| 265 | ENTA | Enanta Pharmaceuticals, Inc. | 410.09M | -0.14% | 407,050 | 65.26M |
| 266 | FHTX | Foghorn Therapeutics Inc. | 406.79M | -0.29% | 293,893 | 36.74M |
| 267 | GALT | Galectin Therapeutics Inc. | 402.39M | 2.84% | 194,698 | - |
| 268 | UPB | Upstream Bio, Inc. | 393.26M | 8.62% | 554,212 | 3.16M |
| 269 | IPSC | Century Therapeutics, Inc. | 392.93M | 2.36% | 542,752 | 109.16M |
| 270 | CUVL | Clinuvel Pharmaceuticals Limited | 382.41M | 2.43% | 14,073 | 64.24M |
| 271 | LYEL | Lyell Immunopharma, Inc. | 379.58M | 5.09% | 102,988 | 27.00K |
| 272 | AGEN | Agenus Inc. | 376.37M | 9.00% | 1,181,096 | 132.69M |
| 273 | ZNTL | Zentalis Pharmaceuticals, Inc. | 367.33M | 3.19% | 798,962 | 26.87M |
| 274 | DMAC | DiaMedica Therapeutics Inc. | 363.46M | 3.37% | 130,944 | - |
| 275 | IFRX | InflaRx N.V. | 362.53M | 20.00% | 3,892,899 | -11.54K |
| 276 | PALI | Palisade Bio, Inc. | 360.74M | 2.99% | 2,067,873 | 500.00K |
| 277 | STRO | Sutro Biopharma, Inc. | 355.50M | 4.64% | 107,966 | 45.70M |
| 278 | ABEO | Abeona Therapeutics Inc. | 355.11M | 2.48% | 785,138 | 25.52M |
| 279 | SABS | SAB Biotherapeutics, Inc. | 346.66M | 5.25% | 359,184 | 114.70K |
| 280 | IRD | Opus Genetics, Inc. | 341.93M | 1.99% | 1,495,476 | 9.86M |
| 281 | IMRX | Immuneering Corporation | 338.37M | 0.97% | 363,075 | - |
| 282 | PRQR | ProQR Therapeutics N.V. | 335.87M | -2.06% | 2,181,860 | 21.05M |
| 283 | AVXL | Anavex Life Sciences Corp. | 329.91M | 14.47% | 2,355,443 | - |
| 284 | YDES | YD Bio Limited | 329.10M | 0.43% | 9,382 | 510.36K |
| 285 | VNDA | Vanda Pharmaceuticals Inc. | 328.92M | 2.06% | 876,139 | 215.72M |
| 286 | OBIO | Orchestra BioMed Holdings, Inc. | 322.16M | -1.47% | 169,578 | 31.98M |
| 287 | VCRE | Vicore Pharma Holding AB (publ) | 319.25M | 0.17% | 10,500 | 412.09K |
| 288 | RNAC | Cartesian Therapeutics, Inc. | 314.05M | 3.18% | 97,554 | 1.48M |
| 289 | BCYC | Bicycle Therapeutics plc | 307.27M | 1.39% | 209,826 | 61.21M |
| 290 | FATE | Fate Therapeutics, Inc. | 305.54M | 4.51% | 2,432,726 | 6.49M |
| 291 | FULC | Fulcrum Therapeutics, Inc. | 294.51M | 0.52% | 1,320,063 | 80.00M |
| 292 | ACIU | AC Immune SA | 290.33M | 2.10% | 241,279 | 21.67M |
| 293 | TTRX | Turn Therapeutics Inc. | 289.84M | 0.52% | 31,385 | - |
| 294 | WHWK | Whitehawk Therapeutics, Inc. | 289.61M | 4.10% | 167,896 | 7.15M |
| 295 | LCTX | Lineage Cell Therapeutics, Inc. | 285.79M | 3.67% | 1,031,957 | 13.08M |
| 296 | SION | Sionna Therapeutics, Inc. | 282.58M | 11.81% | 1,695,898 | - |
| 297 | ELDN | Eledon Pharmaceuticals, Inc. | 282.25M | 1.76% | 970,107 | - |
| 298 | NMRA | Neumora Therapeutics, Inc. | 281.84M | -1.64% | 465,557 | - |
| 299 | CAMP | Camp4 Therapeutics Corporation | 279.25M | 3.01% | 184,477 | 4.22M |
| 300 | IVVD | Invivyd, Inc. | 276.69M | -0.40% | 2,002,523 | 58.37M |
| 301 | ALXO | ALX Oncology Holdings Inc. | 276.55M | 0.50% | 465,965 | - |
| 302 | TRDA | Entrada Therapeutics, Inc. | 274.75M | 3.96% | 269,980 | 4.69M |
| 303 | SRZN | Surrozen, Inc. | 274.56M | -2.54% | 218,967 | 11.51M |
| 304 | GLSI | Greenwich LifeSciences, Inc. | 272.87M | 5.75% | 199,092 | - |
| 305 | CGEN | Compugen Ltd. | 271.86M | 10.81% | 799,271 | 74.00M |
| 306 | SLGL | Sol-Gel Technologies Ltd. | 267.55M | 5.60% | 55,996 | 1.80M |
| 307 | MGNX | MacroGenics, Inc. | 265.63M | 3.73% | 363,134 | 175.14M |
| 308 | ALEC | Alector, Inc. | 263.51M | 2.61% | 557,053 | 13.86M |
| 309 | NAGE | Niagen Bioscience, Inc. | 259.29M | 1.87% | 242,670 | 129.08M |
| 310 | ADAG | Adagene Inc. | 256.49M | -2.05% | 62,870 | 9.29M |
| 311 | PYXS | Pyxis Oncology, Inc. | 255.23M | 3.38% | 421,974 | 11.04M |
| 312 | CLLS | Cellectis S.A. | 249.26M | 7.21% | 15,890 | 63.82M |
| 313 | RNA | Atrium Therapeutics, Inc. | 239.48M | 2.79% | 166,577 | 35.84M |
| 314 | NERV | Minerva Neurosciences, Inc. | 238.74M | 3.95% | 114,277 | - |
| 315 | PEPG | PepGen Inc. | 237.21M | 7.37% | 981,985 | - |
| 316 | DTIL | Precision BioSciences, Inc. | 235.74M | 1.08% | 418,185 | 45.06M |
| 317 | TARA | Protara Therapeutics, Inc. | 234.61M | 2.58% | 272,354 | - |
| 318 | TNXP | Tonix Pharmaceuticals Holding Corp. | 234.28M | 9.72% | 1,142,177 | 29.10M |
| 319 | KROS | Keros Therapeutics, Inc. | 231.58M | 8.35% | 200,322 | 15.01M |
| 320 | ABOS | Acumen Pharmaceuticals, Inc. | 224.18M | 0.81% | 300,701 | - |
| 321 | IMUX | Immunic, Inc. | 224.04M | -0.24% | 231,042 | - |
| 322 | NGEN | NervGen Pharma Corp. | 223.65M | 4.00% | 911,236 | - |
| 323 | NBP | NovaBridge Biosciences | 223.20M | 2.12% | 410,381 | - |
| 324 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 218.75M | 5.80% | 1,279,616 | - |
| 325 | ORMP | Oramed Pharmaceuticals Inc. | 216.72M | 8.09% | 628,464 | 2.00M |
| 326 | VYGR | Voyager Therapeutics, Inc. | 214.43M | 1.16% | 306,480 | 34.46M |
| 327 | ANTX | AN2 Therapeutics, Inc. | 213.59M | 0.53% | 217,706 | - |
| 328 | ACOG | Alpha Cognition Inc. | 212.33M | - | 220,139 | 15.26M |
| 329 | CHRS | Coherus Oncology, Inc. | 211.67M | 0.74% | 1,297,192 | 50.94M |
| 330 | ARMP | Armata Pharmaceuticals, Inc. | 206.73M | 7.54% | 93,981 | 5.54M |
| 331 | IPHA | Innate Pharma S.A. | 205.84M | 2.95% | 27,881 | 10.57M |
| 332 | MSLE | Satellos Bioscience Inc. | 203.85M | -0.74% | 26,845 | - |
| 333 | KRRO | Korro Bio, Inc. | 202.04M | 4.97% | 79,708 | 2.38M |
| 334 | CNXU | Conexeu Sciences Inc. | 202.03M | -3.33% | 315,182 | - |
| 335 | HUMA | Humacyte, Inc. | 194.79M | 5.89% | 5,906,083 | 2.12M |
| 336 | CUE | Cue Biopharma, Inc. | 194.40M | 15.44% | 170,453 | 37.66M |
| 337 | NKTX | Nkarta, Inc. | 194.10M | 4.63% | 456,453 | - |
| 338 | PLX | Protalix BioTherapeutics, Inc. | 193.37M | -0.41% | 497,742 | 80.62M |
| 339 | CRBU | Caribou Biosciences, Inc. | 188.69M | 7.32% | 1,378,209 | 10.04M |
| 340 | CNTN | Canton Strategic Holdings, Inc. | 184.06M | 7.94% | 985,341 | 1.50M |
| 341 | CDXS | Codexis, Inc. | 183.97M | 1.20% | 810,856 | 77.68M |
| 342 | SPRB | Spruce Biosciences, Inc. | 182.21M | 8.10% | 147,015 | 697.00K |
| 343 | MDWD | MediWound Ltd. | 167.45M | -0.23% | 80,357 | 11.86M |
| 344 | MENS | Jyong Biotech Ltd. | 165.54M | 0.45% | 27,694 | - |
| 345 | MOLN | Molecular Partners AG | 165.16M | -0.45% | 2,074 | 856.30K |
| 346 | MIST | Milestone Pharmaceuticals Inc. | 163.46M | 11.54% | 1,705,586 | 2.34M |
| 347 | NRXP | NRx Pharmaceuticals, Inc. | 158.77M | 6.38% | 884,227 | 3.39M |
| 348 | AARD | Aardvark Therapeutics, Inc. | 158.67M | 5.38% | 144,412 | - |
| 349 | KZIA | Kazia Therapeutics Limited | 157.58M | 4.47% | 92,933 | 1.27M |
| 350 | TNYA | Tenaya Therapeutics, Inc. | 157.27M | 3.96% | 1,728,020 | 1.34M |
| 351 | OKUR | OnKure Therapeutics, Inc. | 155.91M | -1.03% | 116,228 | - |
| 352 | OTLK | Outlook Therapeutics, Inc. | 155.81M | 5.09% | 15,918,984 | -1.16M |
| 353 | CNTB | Connect Biopharma Holdings Limited | 154.29M | 6.52% | 635,936 | 2.95M |
| 354 | UNCY | Unicycive Therapeutics, Inc. | 152.37M | 2.43% | 378,501 | - |
| 355 | LENZ | LENZ Therapeutics, Inc. | 146.73M | 1.74% | 542,226 | 21.48M |
| 356 | INDP | Indaptus Therapeutics, Inc. | 145.90M | -5.60% | 496,903 | - |
| 357 | TLSA | Tiziana Life Sciences Ltd | 143.53M | -3.48% | 440,879 | - |
| 358 | EQ | Equillium, Inc. | 138.23M | -0.91% | 575,935 | 4.39M |
| 359 | INO | Inovio Pharmaceuticals, Inc. | 133.38M | 3.20% | 3,602,722 | 65.34K |
| 360 | TENX | Tenax Therapeutics, Inc. | 132.89M | 25.41% | 14,358,072 | - |
| 361 | PMN | ProMIS Neurosciences, Inc. | 132.54M | -0.14% | 60,642 | - |
| 362 | HURA | TuHURA Biosciences, Inc. | 130.00M | -5.12% | 239,378 | - |
| 363 | BDTX | Black Diamond Therapeutics, Inc. | 128.70M | 3.94% | 417,487 | 70.00M |
| 364 | CBUS | Cibus, Inc. | 128.40M | -2.89% | 70,058 | 4.35M |
| 365 | VANI | Vivani Medical, Inc. | 128.09M | 2.90% | 200,407 | - |
| 366 | BMEA | Biomea Fusion, Inc. | 125.40M | 8.81% | 4,357,006 | - |
| 367 | ENGN | enGene Therapeutics Inc. | 125.27M | 3.31% | 1,004,969 | - |
| 368 | GUTS | Fractyl Health, Inc. | 124.77M | 4.51% | 1,620,679 | 3.00K |
| 369 | ANIX | Anixa Biosciences, Inc. | 124.52M | 1.10% | 607,207 | - |
| 370 | RANI | Rani Therapeutics Holdings, Inc. | 124.20M | 1.37% | 782,297 | 4.88M |
| 371 | GNLX | Genelux Corporation | 121.89M | - | 352,905 | 8.00K |
| 372 | COYA | Coya Therapeutics, Inc. | 118.22M | 1.61% | 145,184 | 8.02M |
| 373 | NTHI | NeOnc Technologies Holdings, Inc. | 117.08M | 0.43% | 158,984 | 39.99K |
| 374 | SEER | Seer, Inc. | 112.96M | - | 100,613 | 14.22M |
| 375 | NAUT | Nautilus Biotechnology, Inc. | 112.15M | 0.69% | 482,666 | 190.00K |
| 376 | YARW | Yarrow Bioscience, Inc. | 109.90M | -0.63% | 9,287 | - |
| 377 | ONCY | Oncolytics Biotech Inc. | 109.84M | 2.05% | 765,863 | - |
| 378 | PTHS | Pelthos Therapeutics Inc. | 104.13M | 2.18% | 50,905 | 43.30M |
| 379 | PYPD | PolyPid Ltd. | 103.59M | 2.31% | 139,605 | - |
| 380 | KLRS | Kalaris Therapeutics, Inc. | 99.98M | 2.44% | 26,261 | - |
| 381 | GOSS | Gossamer Bio, Inc. | 99.97M | 16.86% | 47,344,464 | 53.29M |
| 382 | PLYX | Polaryx Therapeutics, Inc. | 99.19M | 6.42% | 106,794 | - |
| 383 | ATRA | Atara Biotherapeutics, Inc. | 98.57M | 3.81% | 48,512 | 6.19M |
| 384 | CGTX | Cognition Therapeutics, Inc. | 97.95M | 4.62% | 414,382 | - |
| 385 | ACET | Adicet Bio, Inc. | 96.88M | 1.12% | 69,861 | - |
| 386 | FBIO | Fortress Biotech, Inc. | 94.38M | -3.41% | 451,311 | 68.47M |
| 387 | ALDX | Aldeyra Therapeutics, Inc. | 93.51M | 1.97% | 411,051 | - |
| 388 | ACRV | Acrivon Therapeutics, Inc. | 93.42M | -0.91% | 242,637 | - |
| 389 | DWTX | Dogwood Therapeutics, Inc. | 91.10M | 4.69% | 123,011 | - |
| 390 | RLYB | Rallybio Corporation | 89.67M | 0.51% | 7,443 | 646.00K |
| 391 | ICCC | ImmuCell Corporation | 89.37M | - | 27,167 | 30.68M |
| 392 | MAIA | MAIA Biotechnology, Inc. | 85.76M | 4.44% | 937,795 | - |
| 393 | CING | Cingulate Inc. | 85.36M | 3.35% | 165,351 | - |
| 394 | VRCA | Verrica Pharmaceuticals Inc. | 84.86M | 1.44% | 54,866 | 30.32M |
| 395 | GANX | Gain Therapeutics, Inc. | 83.14M | -4.75% | 382,851 | - |
| 396 | OKYO | OKYO Pharma Limited | 81.87M | 4.00% | 60,228 | - |
| 397 | TELO | Telomir Pharmaceuticals, Inc. | 81.15M | 0.85% | 40,510 | - |
| 398 | ATHE | Alterity Therapeutics Limited | 79.35M | -2.19% | 21,760 | 4.43M |
| 399 | CRDF | Cardiff Oncology, Inc. | 79.35M | 2.20% | 886,388 | 508.00K |
| 400 | ELTX | Elicio Therapeutics, Inc. | 79.11M | 1.01% | 223,587 | - |
| 401 | ELOX | Eloxx Pharmaceuticals, Inc. | 77.86M | -3.50% | 33,812 | - |
| 402 | ANVS | Annovis Bio, Inc. | 77.54M | 4.00% | 560,120 | - |
| 403 | MNOV | MediciNova, Inc. | 77.28M | 2.61% | 87,089 | 920.48K |
| 404 | OSTX | OS Therapies Incorporated | 76.11M | 6.45% | 332,562 | - |
| 405 | NRXS | NeurAxis, Inc. | 75.85M | -0.49% | 73,304 | 5.32M |
| 406 | LONA | LeonaBio, Inc. | 75.47M | 3.62% | 11,690 | - |
| 407 | PLRX | Pliant Therapeutics, Inc. | 73.69M | 4.39% | 321,922 | - |
| 408 | IBIO | iBio, Inc. | 73.03M | 3.52% | 425,265 | 300.00K |
| 409 | SPRO | Spero Therapeutics, Inc. | 71.63M | 1.23% | 645,512 | 47.00M |
| 410 | XBIT | XBiotech Inc. | 70.12M | -0.43% | 52,244 | - |
| 411 | EXOZ | eXoZymes, Inc. | 69.89M | 8.35% | 3,222 | -700.00 |
| 412 | PMVP | PMV Pharmaceuticals, Inc. | 69.76M | - | 211,662 | - |
| 413 | CSBR | Champions Oncology, Inc. | 69.19M | 0.20% | 2,399 | 59.43M |
| 414 | RNTX | Rein Therapeutics Inc. | 69.01M | - | 276,751 | - |
| 415 | SER | Serina Therapeutics, Inc. | 68.58M | 2.66% | 24,886 | 130.00K |
| 416 | BSEM | BioStem Technologies, Inc. | 68.01M | -2.81% | 62,739 | 34.59M |
| 417 | INMB | INmune Bio Inc. | 67.44M | 2.97% | 248,570 | 50.00K |
| 418 | BOLD | Boundless Bio, Inc. | 66.87M | -0.68% | 41,142 | - |
| 419 | HYFT | MindWalk Holdings Corp. | 66.72M | 2.90% | 120,425 | 11.43M |
| 420 | RNXT | RenovoRx, Inc. | 64.08M | 13.60% | 1,310,815 | 1.98M |
| 421 | IMA | ImageneBio, Inc. | 63.00M | -1.25% | 16,675 | 800.00K |
| 422 | HRTX | Heron Therapeutics, Inc. | 61.34M | 0.09% | 1,624,127 | 151.18M |
| 423 | EDSA | Edesa Biotech, Inc. | 60.13M | 1.14% | 108,314 | - |
| 424 | XLO | Xilio Therapeutics, Inc. | 59.75M | -1.20% | 5,895 | 64.09M |
| 425 | NTRB | Nutriband Inc. | 58.71M | -5.48% | 37,714 | 1.80M |
| 426 | APLM | Apollomics, Inc. | 58.20M | 14.68% | 10,546 | 8.84M |
| 427 | IMMP | Immutep Limited | 56.93M | -1.06% | 58,183 | 5.28M |
| 428 | INKT | MiNK Therapeutics, Inc. | 56.69M | -3.72% | 9,350 | - |
| 429 | ATYR | aTyr Pharma, Inc. | 55.91M | 7.55% | 675,514 | 190.00K |
| 430 | TCRX | TScan Therapeutics, Inc. | 53.80M | -0.70% | 180,597 | 7.11M |
| 431 | HYPD | Hyperion DeFi, Inc. | 52.99M | 4.60% | 808,126 | 1.40M |
| 432 | ALPS | Alps Group Inc | 52.38M | -0.06% | 17,930 | 3.74M |
| 433 | TIL | Instil Bio, Inc. | 51.54M | -2.69% | 5,377 | - |
| 434 | MCRB | Seres Therapeutics, Inc. | 49.71M | 7.30% | 102,957 | 1.88M |
| 435 | IBO | Impact BioMedical Inc. | 49.62M | 1.59% | 53,828 | 35.00K |
| 436 | ALGS | Aligos Therapeutics, Inc. | 46.65M | 7.79% | 91,472 | 31.52M |
| 437 | GRCE | Grace Therapeutics, Inc. | 46.28M | 0.92% | 92,478 | - |
| 438 | VERU | Veru Inc. | 46.21M | 4.63% | 226,919 | 16.89M |
| 439 | FLNA | Filana Therapeutics, Inc. | 45.83M | 2.02% | 109,993 | - |
| 440 | MGX | Metagenomi Therapeutics, Inc. | 45.71M | - | 124,875 | 13.56M |
| 441 | TVGN | Tevogen Inc. | 45.39M | 2.35% | 2,601 | - |
| 442 | MREO | Mereo BioPharma Group plc | 44.97M | -2.73% | 1,143,665 | 500.00K |
| 443 | VRXA | Veraxa Biotech AG | 43.63M | -2.81% | 145,673 | - |
| 444 | KPTI | Karyopharm Therapeutics Inc. | 43.55M | 3.23% | 1,023,773 | 146.62M |
| 445 | HOWL | Werewolf Therapeutics, Inc. | 43.25M | 0.76% | 6,352,756 | 21.00M |
| 446 | RNAZ | TransCode Therapeutics, Inc. | 42.83M | -6.30% | 136,627 | - |
| 447 | CRVO | CervoMed Inc. | 40.07M | 0.76% | 219,958 | 331.30K |
| 448 | CNTX | Context Therapeutics Inc. | 40.00M | -6.45% | 8,159,729 | - |
| 449 | ACTU | Actuate Therapeutics, Inc. | 37.94M | 28.46% | 556,200 | - |
| 450 | LITS | Lite Strategy, Inc. | 35.73M | 1.94% | 318,046 | - |
| 451 | ATNM | Actinium Pharmaceuticals, Inc. | 33.96M | 2.86% | 159,002 | 35.09M |
| 452 | KYNB | Kyntra Bio, Inc. | 32.80M | 1.50% | 45,179 | 4.62M |
| 453 | RADX | Radiopharm Theranostics Limited | 32.58M | 1.64% | 34,608 | 10.86M |
| 454 | ESLA | Estrella Immunopharma, Inc. | 31.86M | -0.34% | 38,279 | - |
| 455 | IGC | IGC Pharma, Inc. | 31.49M | 1.33% | 362,238 | 1.11M |
| 456 | QNCX | Quince Therapeutics, Inc. | 31.46M | -7.62% | 17,233 | - |
| 457 | BCTX | BriaCell Therapeutics Corp. | 30.32M | 8.96% | 643,081 | - |
| 458 | BYSI | BeyondSpring Inc. | 29.61M | 1.55% | 44,388 | 1.88M |
| 459 | NNVC | NanoViricides, Inc. | 29.39M | 1.57% | 237,696 | - |
| 460 | GRDX | GridAI Technologies Corp. | 28.75M | 11.23% | 145,551 | - |
| 461 | EVAX | Evaxion A/S | 27.94M | -1.47% | 148,839 | 7.49M |
| 462 | LTRN | Lantern Pharma Inc. | 27.87M | 3.32% | 123,986 | - |
| 463 | QNTM | Quantum BioPharma Ltd. | 27.61M | 1.23% | 143,208 | - |
| 464 | GNTA | Genenta Science S.p.A. | 27.13M | - | 82,788 | - |
| 465 | NXTC | NextCure, Inc. | 27.05M | 0.34% | 160,393 | - |
| 466 | BRNS | Barinthus Biotherapeutics plc | 26.96M | 9.43% | 46,592 | 14.97M |
| 467 | ATOS | Atossa Therapeutics, Inc. | 26.74M | 1.52% | 49,680 | - |
| 468 | ENLV | Enlivex Ltd. | 26.58M | 0.66% | 155,283 | - |
| 469 | CVM | CEL-SCI Corporation | 26.03M | 7.25% | 86,414 | - |
| 470 | MRKR | Marker Therapeutics, Inc. | 25.34M | 1.33% | 146,717 | 3.55M |
| 471 | DYAI | Dyadic International, Inc. | 25.18M | 1.72% | 57,564 | 3.80M |
| 472 | TVRD | Tvardi Therapeutics, Inc. | 24.28M | 2.25% | 77,061 | - |
| 473 | CLRB | Cellectar Biosciences, Inc. | 24.01M | 0.79% | 16,663 | - |
| 474 | JSPR | Jasper Therapeutics, Inc. | 23.96M | -0.30% | 268,466 | - |
| 475 | CNSY | Cerenome, Inc. | 23.41M | 4.22% | 29,625 | 4.20M |
| 476 | NIKI | Niki BioSolutions, Inc. | 23.23M | -1.31% | 22,415 | - |
| 477 | CELU | Celularity Inc. | 23.18M | 3.36% | 1,075,262 | 26.55M |
| 478 | COCP | Cocrystal Pharma, Inc. | 21.77M | 1.80% | 71,819 | 330.00K |
| 479 | LGVN | Longeveron Inc. | 21.68M | -18.84% | 1,566,895 | 1.19M |
| 480 | ALLR | Allarity Therapeutics, Inc. | 21.16M | -4.32% | 56,551 | 345.00K |
| 481 | NEUP | Neuphoria Therapeutics Inc. | 20.86M | -2.28% | 33,645 | -13.27K |
| 482 | ABVC | ABVC BioPharma, Inc. | 20.74M | -4.77% | 76,000 | 797.92K |
| 483 | PLRZ | Polyrizon Ltd. | 20.40M | 1.87% | 42,667 | - |
| 484 | CALC | CalciMedica, Inc. | 20.08M | 5.68% | 217,222 | - |
| 485 | LEXX | Lexaria Bioscience Corp. | 19.17M | 10.06% | 12,259 | 194.00K |
| 486 | NCEL | NewcelX Ltd. | 18.74M | 0.58% | 16,970 | - |
| 487 | KTTA | Pasithea Therapeutics Corp. | 18.71M | 10.89% | 223,620 | - |
| 488 | CYCN | Cyclerion Therapeutics, Inc. | 18.43M | 1.78% | 77,889 | 1.90M |
| 489 | PLUR | Pluri Inc. | 17.91M | 6.41% | 18,950 | 1.08M |
| 490 | TPST | Tempest Therapeutics, Inc. | 17.74M | 0.91% | 72,421 | - |
| 491 | LPCN | Lipocine Inc. | 17.73M | 4.37% | 11,788 | 1.57M |
| 492 | PTN | Palatin Technologies, Inc. | 17.24M | 2.07% | 106,658 | 12.88M |
| 493 | BCDA | BioCardia, Inc. | 17.11M | 6.60% | 350,261 | 3.00K |
| 494 | CMMB | Chemomab Therapeutics Ltd. | 16.66M | 5.99% | 139,565 | - |
| 495 | CTXR | Citius Pharmaceuticals, Inc. | 16.57M | 4.92% | 2,160,317 | 7.11M |
| 496 | PBM | Psyence Biomedical Ltd. | 16.29M | 1.18% | 43,254 | - |
| 497 | INTS | Intensity Therapeutics, Inc. | 15.98M | 3.05% | 103,860 | - |
| 498 | KALA | KALA BIO, Inc. | 15.88M | 3.22% | 15,993 | - |
| 499 | BIVI | BioVie Inc. | 15.76M | -2.34% | 1,019,921 | - |
| 500 | LSTA | Lisata Therapeutics, Inc. | 15.68M | -1.14% | 182,338 | 100.00K |